{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:20:25Z","timestamp":1787066425458,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.arbres.2025.07.024","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T21:38:21Z","timestamp":1754429901000},"page":"610-616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Residual Excessive Daytime Sleepiness in Obstructive Sleep Apnoea and New Pharmacological Possibilities for Treatment"],"prefix":"10.1016","volume":"61","author":[{"given":"Grace","family":"Oscullo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Bekki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Daniel","family":"G\u00f3mez-Olivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Mart\u00ednez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2025.07.024_bib0250","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S2213-2600(19)30198-5","article-title":"Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis","volume":"7","author":"Benjafield","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.arbres.2025.07.024_bib0255","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jsmc.2024.10.009","article-title":"Intermittent hypoxia as a model of obstructive sleep apnea: present and future","volume":"20","author":"Badran","year":"2025","journal-title":"Sleep Med Clin"},{"issue":"1","key":"10.1016\/j.arbres.2025.07.024_bib0260","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.arbres.2021.03.017","article-title":"International consensus document on obstructive sleep apnea","volume":"58","author":"Mediano","year":"2022","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2025.07.024_bib0265","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.arbres.2023.03.012","article-title":"Effect of continuous positive airway pressure on glucose and lipid profiles in patients with obstructive sleep apnoea: a systematic review and meta-analysis of randomized controlled trials","volume":"59","author":"Cattazzo","year":"2023","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2025.07.024_bib0270","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.arbres.2022.11.001","article-title":"Cardiovascular protection in sleep apnea: is it a question of CPAP adherence?","volume":"59","author":"Bailly","year":"2023","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2025.07.024_bib0275","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.arbres.2023.03.006","article-title":"What is the best antihypertensive treatment for OSA?","volume":"59","author":"Lima-Junior","year":"2023","journal-title":"Arch Bronconeumol"},{"issue":"10","key":"10.1016\/j.arbres.2025.07.024_bib0280","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.arbres.2024.05.029","article-title":"Effect of CPAP treatment on cardiovascular outcomes","volume":"60","author":"de Batlle","year":"2024","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2025.07.024_bib0285","doi-asserted-by":"crossref","first-page":"101275","DOI":"10.1016\/j.smrv.2020.101275","article-title":"The economic and societal burden of excessive daytime sleepiness in patients with obstructive sleep apnea","volume":"51","author":"Leger","year":"2020","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.arbres.2025.07.024_bib0290","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1513\/AnnalsATS.202006-696FR","article-title":"Excessive daytime sleepiness in obstructive sleep apnea mechanisms and clinical management","volume":"18","author":"Lai","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.arbres.2025.07.024_bib0295","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/MCP.0000000000000324","article-title":"Residual excessive sleepiness in patients with obstructive sleep apnea on treatment with continuous positive airway pressure","volume":"22","author":"Dongol","year":"2016","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.arbres.2025.07.024_bib0300","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1183\/09031936.00016808","article-title":"Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study","volume":"33","author":"Pepin","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2025.07.024_bib0305","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1183\/09031936.00124708","article-title":"Predictors of residual sleepiness in adequately treated obstructive sleep apnoea patients","volume":"34","author":"Koutsourelakis","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2025.07.024_bib0310","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jsr.12039","article-title":"Residual sleepiness in sleep apnea patients treated by continuous positive airway pressure","volume":"22","author":"Gasa","year":"2013","journal-title":"J Sleep Res"},{"key":"10.1016\/j.arbres.2025.07.024_bib0315","doi-asserted-by":"crossref","first-page":"210230","DOI":"10.1183\/16000617.0230-2021","article-title":"Investigation and management of residual sleepiness in CPAP-treated patients with obstructive sleep apnoea: the European view","volume":"31","author":"Craig","year":"2022","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.arbres.2025.07.024_bib0320","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.smrv.2011.01.003","article-title":"A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions","volume":"15","author":"Sawyer","year":"2011","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.arbres.2025.07.024_bib0325","doi-asserted-by":"crossref","first-page":"874e88","DOI":"10.1016\/j.clinthera.2016.02.004","article-title":"Effects of modafinil and armodafinil in patients with obstructive sleep apnea: a meta-analysis of randomized controlled trials","volume":"38","author":"Kuan","year":"2016","journal-title":"Clin Therap"},{"key":"10.1016\/j.arbres.2025.07.024_bib0330","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1183\/13993003.01509-2015","article-title":"Modafinil\/armodafinil in obstructive sleep apnoea: a systematic review and meta-analysis","volume":"47","author":"Chapman","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2025.07.024_bib0335","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1476-5381.2011.01286.x","article-title":"The histamine H3 receptor: from discovery to clinical trials with pitolisant","volume":"163","author":"Schwartz","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.arbres.2025.07.024_bib0340","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s40263-023-01040-5","article-title":"Solriamfetol: a review in excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnoea","volume":"37","author":"Hoy","year":"2023","journal-title":"CNS Drugs"},{"issue":"164","key":"10.1016\/j.arbres.2025.07.024_bib0345","doi-asserted-by":"crossref","first-page":"210230","DOI":"10.1183\/16000617.0230-2021","article-title":"Investigation and management of residual sleepiness in CPAP-treated patients with obstructive sleep apnoea: the European view","volume":"31","author":"Craig","year":"2022","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.arbres.2025.07.024_bib0350","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/17476348.2025.2479614","article-title":"Management options for excessive daytime sleepiness in patients with obstructive sleep apnea","volume":"19","author":"Bonsignore","year":"2025","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.arbres.2025.07.024_bib0355","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.sleep.2023.10.001","article-title":"Recommendations for clinical management of excessive daytime sleepiness in obstructive sleep apnoea \u2013 a Delphi consensus study","volume":"112","author":"Steier","year":"2023","journal-title":"Sleep Med"},{"issue":"2","key":"10.1016\/j.arbres.2025.07.024_bib0360","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s40120-021-00289-6","article-title":"Current management of residual excessive daytime sleepiness due to obstructive sleep apnea: insights for optimizing patient outcomes","volume":"10","author":"Mehra","year":"2021","journal-title":"Neurol Ther"},{"key":"10.1016\/j.arbres.2025.07.024_bib0365","first-page":"101105","article-title":"Guidelines for the assessment and management of residual sleepiness in obstructive apnea\u2013hypopnea syndrome: Endorsed by the French Sleep Research and Medicine Society (SFRMS) and the French Speaking Society of Respiratory Diseases (SPLF)","volume":"86","author":"Barateau","year":"2024","journal-title":"Respir Med Res"},{"key":"10.1016\/j.arbres.2025.07.024_bib0370","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/sleep\/30.6.711","article-title":"Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning","volume":"30","author":"Weaver","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.arbres.2025.07.024_bib0375","doi-asserted-by":"crossref","first-page":"101997","DOI":"10.1016\/j.smrv.2024.101997","article-title":"Excessive daytime sleepiness in obstructive sleep apnea: Indirect treatment comparison of wake-promoting agents in patients adherent\/nonadherent to primary OSA therapy","volume":"78","author":"Wang","year":"2024","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.arbres.2025.07.024_bib0380","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11325-019-01830-6","article-title":"Residual excessive daytime sleepiness in patients with obstructive sleep apnea treated with positive airway pressure therapy","volume":"24","author":"Foster","year":"2020","journal-title":"Sleep Breath"},{"key":"10.1016\/j.arbres.2025.07.024_bib0385","doi-asserted-by":"crossref","first-page":"101934","DOI":"10.1016\/j.smrv.2024.101934","article-title":"Evaluating pharmacological treatments for excessive daytime sleepiness in obstructive sleep apnea: a comprehensive network meta-analysis and systematic review","volume":"76","author":"Neshat","year":"2024","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.arbres.2025.07.024_bib0390","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.sleep.2006.05.016","article-title":"Attention-deficit\/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study","volume":"8","author":"Huang","year":"2007","journal-title":"Sleep Med"},{"key":"10.1016\/j.arbres.2025.07.024_bib0395","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.clinthera.2016.02.004","article-title":"Effects of modafinil and armodafinil in patients with obstructive sleep apnea: a meta-analysis of randomized controlled trials","volume":"38","author":"Kuan","year":"2016","journal-title":"Clin Therap"},{"key":"10.1016\/j.arbres.2025.07.024_bib0400","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1183\/13993003.01509-2015","article-title":"Modafinil\/armodafinil in obstructive sleep apnoea: a systematic review and meta-analysis","volume":"47","author":"Chapman","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2025.07.024_bib0405","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.5665\/sleep.2204","article-title":"A randomized, double-blind, placebo-controlled study of an oral, extended-release formulation of phentermine\/topiramate for the treatment of obstructive sleep apnea in obese adults","volume":"35","author":"Winslow","year":"2012","journal-title":"Sleep"},{"key":"10.1016\/j.arbres.2025.07.024_bib0410","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.sleep.2009.06.006","article-title":"A safety trial of sodium oxybate in patients with obstructive sleep apnea: acute effects on sleep-disordered breathing","volume":"11","author":"George","year":"2010","journal-title":"Sleep Med"},{"key":"10.1016\/j.arbres.2025.07.024_bib0415","unstructured":"https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/wakix [accessed 19.07.25]."},{"key":"10.1016\/j.arbres.2025.07.024_bib0420","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.chest.2020.09.281","article-title":"Pitolisant for residual excessive daytime sleepiness in OSA patients adhering to CPAP: a randomized trial","volume":"159","author":"P\u00e9pin","year":"2021","journal-title":"Chest."},{"key":"10.1016\/j.arbres.2025.07.024_bib0425","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1164\/rccm.201907-1284OC","article-title":"Pitolisant for daytime sleepiness in patients with obstructive sleep apnea who refuse continuous positive airway pressure treatment. A randomized trial","volume":"201","author":"Dauvilliers","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2025.07.024_bib0430","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s40261-021-01104-8","article-title":"Efficacy of pitolisant 20 mg in reducing excessive daytime sleepiness and fatigue in patients with obstructive sleep apnoea syndrome: an individual patient data meta-analysis","volume":"42","author":"Lehert","year":"2022","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.arbres.2025.07.024_bib0435","doi-asserted-by":"crossref","first-page":"e14373","DOI":"10.1111\/jsr.14373","article-title":"Pitolisant 40mg for excessive daytime sleepiness in obstructive sleep apnea patients treated or not by CPAP: randomised phase 3 study","volume":"34","author":"Dauvilliers","year":"2025","journal-title":"J Sleep Res."},{"key":"10.1016\/j.arbres.2025.07.024_bib0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sleep.2025.02.003","article-title":"Efficacy and safety of pitolisant in residual excessive daytime sleepiness for patients with obstructive sleep apnea adhering to continuous positive airway pressure therapy in the HAROSA studies: an individual patient meta-analytical approach","volume":"129","author":"Testelmans","year":"2025","journal-title":"Sleep Med"},{"issue":"Suppl. 1","key":"10.1016\/j.arbres.2025.07.024_bib0445","doi-asserted-by":"crossref","first-page":"e186","DOI":"10.1016\/j.sleep.2017.11.544","article-title":"Epworth sleepiness scale ESS: determination of a minimum clinically relevant difference","volume":"40","author":"Lehert","year":"2017","journal-title":"Sleep Med"},{"key":"10.1016\/j.arbres.2025.07.024_bib0450","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/thoraxjnl-2018-211959","article-title":"Minimum important difference of the Epworth Sleepiness Scale in obstructive sleep apnoea: estimation from three randomized controlled trials","volume":"74","author":"Crook","year":"2019","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2025.07.024_bib0455","doi-asserted-by":"crossref","first-page":"e1161","DOI":"10.1002\/prp2.1161","article-title":"Is pitolisant safe for clinical use? A retrospective pharmacovigilance study focus on the post-marketing safety","volume":"12","author":"Jiang","year":"2024","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.arbres.2025.07.024_bib0460","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.chest.2023.11.017","article-title":"Long-term efficacy and safety of pitolisant for residual sleepiness due to OSA","volume":"165","author":"P\u00e9pin","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2025.07.024_bib0465","first-page":"785e90","article-title":"Solriamfetol: first global approval","volume":"79","author":"Markham","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.arbres.2025.07.024_bib0470","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1016\/j.sleep.2017.11.875","article-title":"Results of a randomized, placebo-controlled, double-blind, 12-week, multicenter study of solriamfetol (JZP-110) for the treatment of excessive sleepiness in patients with obstructive sleep apnea","volume":"40","author":"Schweitzer","year":"2017","journal-title":"Sleep Med"},{"key":"10.1016\/j.arbres.2025.07.024_bib0475","doi-asserted-by":"crossref","first-page":"A1092e3","DOI":"10.1016\/j.chest.2017.08.1126","article-title":"Treatment of excessive sleepiness in patients with OSA: efficacy and safety results of a 6-week, double-blind, placebo-controlled, randomized-withdrawal trial of JZP-110","volume":"152","author":"Strollo","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2025.07.024_bib0480","doi-asserted-by":"crossref","first-page":"zsz220","DOI":"10.1093\/sleep\/zsz220","article-title":"Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea","volume":"43","author":"Malhotra","year":"2020","journal-title":"Sleep"},{"key":"10.1016\/j.arbres.2025.07.024_bib0485","doi-asserted-by":"crossref","first-page":"659","DOI":"10.5664\/jcsm.8992","article-title":"Effects of solriamfetol in a long-term of participants with obstructive sleep apnea who are adherent or nonadherent to airway therapy","volume":"17","author":"Schweitzer","year":"2021","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.arbres.2025.07.024_bib0490","doi-asserted-by":"crossref","first-page":"510e521","DOI":"10.1016\/j.sleep.2020.09.019","article-title":"Efficacy and safety of solriamfetol for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea: a systematic review and meta-analysis of clinical trials","volume":"75","author":"Subedi","year":"2020","journal-title":"Sleep Med"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289625002923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289625002923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T22:15:14Z","timestamp":1759875314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289625002923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0300289625002923"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2025.07.024","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Residual Excessive Daytime Sleepiness in Obstructive Sleep Apnoea and New Pharmacological Possibilities for Treatment","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2025.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 SEPAR. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}